Moreover, the activated tumor-infiltrating CD8+ T cell population and granzyme B expression were increased in the mice treated with the ODN1585 and anti-PD-1 antibody combination (Figure 5B, Figure S4A), indicating that this combination treatment improved immune activity in the mice. The gene discussed is CD8A; the disease is neoplasm.